QR kód

Apixaban Enhances Vasodilatation Mediated by Protease-Activated Receptor 2 in Isolated Rat Arteries

Apixaban (APX) is a direct inhibitor of factor X (FXa) approved for prophylaxis and treatment of deep venous thrombosis and atrial fibrillation. Because FXa activates protease-activated receptor 2 (PAR-2) in endothelium and vascular smooth muscle, inhibition of FXa by APX may affect vasomotor functi...

Celý popis

Uloženo v:
Hlavní autoři: Ambra Villari, Giovanni Giurdanella, Claudio Bucolo, Filippo Drago, Salvatore Salomone
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2017-07-01
Edice:Frontiers in Pharmacology
Témata:
apixaban
PAR-2
isolated artery
vasodilatation
endothelium
SLIGRL
On-line přístup:http://journal.frontiersin.org/article/10.3389/fphar.2017.00480/full
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky